(This is a cross-post from Steptoe’s new Investigations and Enforcement Blog.)
The Department of Justice Antitrust Division’s investigation into price-fixing by generic drug companies continues to remain one of the Antitrust Division’s most active matters. This week the Antitrust Division announced that it had indicted Teva Pharmaceuticals USA Inc. (Teva), the seventh company to reach a resolution with the Antitrust Division in this investigation. Teva is one of the largest pharmaceutical companies in the world.
Continue Reading Another Generic Drug Company Accepts a Criminal Indictment Alleging Collusion